Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New Patent Could Be Worth $6 A Share To Amgen
New Patent Could Be Worth $6 A Share To Amgen
New Patent Could Be Worth $6 A Share To Amgen
Submitted by
admin
on November 28, 2011 - 9:55am
Source:
Forbes
News Tags:
Amgen
patents
Enbrel
rheumatoid arthritis
Headline:
New Patent Could Be Worth $6 A Share To Amgen
Do Not Allow Advertisers to Use My Personal information
